Sphingosine-d7 (d18:1) (Synonyms: (-)-Sphingosine-d7, D-erythro-Sphingosine C-18-d7) |
Catalog No.GC40104 |
La sphingosine-d7 (d18:1) (érythrosphingosine-d7) est la D-érythro-sphingosine marquée au deutérium. La D-érythro-sphingosine (érythrosphingosine) est un activateur très puissant de la p32-kinase avec une EC50 de 8 μ ; M, et inhibe la protéine kinase C (PKC). La D-érythro-Sphingosine (Erythrosphingosine) est également un activateur de la PP2A.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1246304-34-6
Sample solution is provided at 25 µL, 10mM.
Sphingosine-d7 (d18:1) is intended for use as an internal standard for the quantification of sphingosine (d18:1) by GC- or LC-MS. Sphingosine (d18:1) is formed primarily from the breakdown of ceramide. Sphingosine (d18:1) inhibits protein kinase C and phosphatidic acid phosphohydrolase, whereas it activates phospholipase D and diacylglycerol (DAG) kinase. Phosphorylation of sphingosine (d18:1) by sphingosine kinases 1 and 2 (SPHK1, SPHK2) produces sphingosine-1-phosphate, a potent bioactive lipid that exhibits a broad spectrum of biological activities including cell proliferation, survival, migration, cytoskeletal organization, and morphogenesis.
Average Rating: 5
(Based on Reviews and 6 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *